CLINICIP

Improved survival chances for critically ill patients and increased efficiency and safety in clinical practice: CLINICIP clinicians and scientists have joined forces in order to develop an intelligent glucose monitoring and control system for critically ill patients.The CLINICIP system will help to improve the survival chances in intensive care units and to increase efficiency and safety in clinical practice.

Hyperglycaemia and insulin resistance are common in critically ill patients, even when glucose homeostasis has previously been normal. Recent medical studies brought evidence that treatment of high glucose levels with insulin will dramatically improve survival chances in these patients. However, treatment of glycaemia with target glucose levels close to physiological range is labour-intensive and although the cause/effect is well-known, the unmanageable workload and the prevalent fear of hypoglycaemiae among critical care physicians still prevent the general implementation of glycaemic control in the intensive care unit.

Therefore, the overall goal of CLINICIP is to establish glycaemic control on an automated basis in order to improve survival chances in intensive care units.

For further information, please visit:
http://www.clinicip.org

Project co-ordinator:
JOANNEUM RESEARCH Forschungsgesellschaft mbH

Partners:

  • JOANNEUM RESEARCH Forschungsgesellschaft mbH (AT)
  • Disetronic Medical Systems AG (CH)
  • Medizinische Universität Graz (AT)
  • Technische Universität Graz (AT)
  • Univerzita Karlova V Praze (CZ)
  • Royal Brompton and Harefield NHS Trust (UK)
  • Consiglio Nazionale delle Ricerche (IT)
  • SensLab Gesellschaft zur Entwicklung und Herstellung bioelektrochemischer Sensoren mbH (DE)
  • Gesellschaft zur Förderung der Analytischen Wissenschaften e.V. (DE)
  • GAMBRO Dialysatoren GmbH (DE)
  • Katholieke Universiteit Leuven (BE)
  • The Chancellor, Masters and Scholars of the University of Cambridge (UK)
  • B.Braun Melsungen AG (DE)

Timetable: 01/04 - to 12/07

Total cost: € 11.256.588

EC funding: € 7.500.000

Instrument: IP

Project Identifier: IST-2002-506965

Most Popular Now

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...

AI Body Composition Measurements can Pre…

Adiposity - or the accumulation of excess fat in the body - is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease...